Skip to main content

Articles

Page 4 of 75

  1. The hypoxia-responsive long non-coding RNA, RP11-367G18.1, has recently been reported to induce histone 4 lysine 16 acetylation (H4K16Ac) through its variant 2; however, the underlying molecular mechanism remains...

    Authors: Pei-Hua Peng, Ji-Lin Chen, Heng-Hsiung Wu, Wen-Hao Yang, Li-Jie Lin, Joseph Chieh-Yu Lai, Jeng-Shou Chang, Jia-Ling Syu, Han-Tsang Wu, Fei-Ting Hsu, Wei-Chung Cheng and Kai-Wen Hsu
    Citation: Cancer Cell International 2023 23:266
  2. V-domain immunoglobulin suppressor of T cell activation (VISTA) is a novel negative checkpoint receptor (NCR) primarily involved in maintaining immune tolerance. It has a role in the pathogenesis of autoimmune...

    Authors: Najibeh Shekari, Dariush Shanehbandi, Tohid Kazemi, Habib Zarredar, Behzad Baradaran and Seyed Amir Jalali
    Citation: Cancer Cell International 2023 23:265
  3. "Inflammatory bowel disease" (IBD) is a chronic, relapsing inflammatory disease of the intestinal tract that typically begins at a young age and might transit to colorectal cancer (CRC). In this manuscript, we...

    Authors: Zeinab Deris Zayeri, Abazar Parsi, Saeid Shahrabi, Masoud Kargar, Nader Davari and Najmaldin Saki
    Citation: Cancer Cell International 2023 23:264
  4. Gamma-butyrobetaine hydroxylase 1 antisense RNA 1 (BBOX1-AS1), located on human chromosome 11 p14, emerges as a critical player in tumorigenesis with diverse oncogenic effects. Aberrant expression of BBOX1-AS1...

    Authors: Juan Hu, Jipeng Liu, Siwei Zhou and Hongliang Luo
    Citation: Cancer Cell International 2023 23:263
  5. Gene status has become the focus of prognosis prediction. Furthermore, deep learning has frequently been implemented in medical imaging to diagnose, prognosticate, and evaluate treatment responses in patients ...

    Authors: Jie Peng, Lushan Xiao, Hongbo Zhu, Lijie Han and Honglian Ma
    Citation: Cancer Cell International 2023 23:262
  6. There is a growing interest to understand the role and mechanism of action of microRNAs (miRNAs) in cancer. The miRNAs are defined as short non-coding RNAs (18-22nt) that regulate fundamental cellular processe...

    Authors: Ali Ameri, Hani Moslem Ahmed, Renzon Daniel Cosme Pecho, Hesamoddin Arabnozari, Hoda Sarabadani, Romina Esbati, Seyedsaber Mirabdali and Omid Yazdani
    Citation: Cancer Cell International 2023 23:261
  7. Circular RNA RHOT1 (circRHOT1) plays crucial roles in tumorigenesis by competing with microRNAs. It is largely abundant in tumor cell-derived exosomes. Meanwhile, cancer-derived exosomes participate in diverse...

    Authors: Weihua Jiang, YinPing Yu, Jianghua Ou, Yongtao Li and Ning Zhu
    Citation: Cancer Cell International 2023 23:260
  8. Disulfidptosis and the disulfidptosis-related gene SLC7A11 have recently attracted significant attention for their role in tumorigenesis and tumour management. However, its association with adrenocortical carc...

    Authors: Tonghu Liu, Yilin Ren, Qixin Wang, Yu Wang, Zhiyuan Li, Weibo Sun, Dandan Fan, Yongkun Luan, Yukui Gao and Zechen Yan
    Citation: Cancer Cell International 2023 23:259
  9. Metastasis is still a major cause of poor pathological outcome and prognosis in esophageal squamous cell carcinoma (ESCC) patients. NUAK1 has been reported highly expressed in many human cancers and is associa...

    Authors: Huiru Yang, Zhen Wei, Yifan Song, Kexin Du, Nannan Yin, Hong Lu, Bingbing Li, Lili Hou, Panfei Xing, Liang Chen, Chaojie Wang and Songqiang Xie
    Citation: Cancer Cell International 2023 23:258
  10. Cancer cells promote glycolysis, which supports rapid cell growth and proliferation. Phosphofructokinase-fructose bisphosphatases (PFKFBs), a family of bidirectional glycolytic enzymes, play key roles in the r...

    Authors: Kai-Fang Hu, Chih-Wen Shu, Cheng-Hsin Lee, Ching-Jiunn Tseng, Yu-Hsiang Chou and Pei-Feng Liu
    Citation: Cancer Cell International 2023 23:257
  11. Gastrointestinal stromal tumors (GIST) represent a significant clinical challenge due to their metastatic potential and limited treatment options. Raf kinase inhibitor protein (RKIP), a suppressor of the MAPK ...

    Authors: Nathália Cristina Campanella, Izabela Natalia Faria Gomes, Ana Laura Vieira Alves, Leticia Ferro Leal, Adriane Feijó Evangelista, Marcela Nunes Rosa, Matias Eliseo Melendez, Viviane Aline Oliveira Silva, Richard Lucas Konichi Dias, Lucas Faria Abrahão-Machado, Iara Santana, Olga Martinho, Denise Peixoto Guimarães, Vitor Marcel Faça and Rui Manuel Reis
    Citation: Cancer Cell International 2023 23:256
  12. THBS2, a member of the extracellular matrix glycoprotein family, can effectively inhibit tumour growth and angiogenesis. This study aimed to investigate the biological role of THBS2 in various types of cancers...

    Authors: Ye Liu, Chunhui Jiang, Chunjie Xu and Lei Gu
    Citation: Cancer Cell International 2023 23:253
  13. Tumor-derived extracellular vesicles (EVs) have been proposed as the essential mediator between host immunity and cancer development. These EVs conduct cellular communication to facilitate tumor growth, enable...

    Authors: Hsin-Pei Weng, Chiao-Hsu Ke, Chun-Wei Tung, Akiyoshi Tani, Chia-Chi Wang, Wen-Yuan Yang, Yu-Shan Wang, Winston Han, Chi-Hsun Liao, Hirotaka Tomiyasu and Chen-Si Lin
    Citation: Cancer Cell International 2023 23:252
  14. Bladder cancer (BC) is the sixth most common worldwide urologic malignancy associated with elevated morbidity and mortality rates if not well treated. The muscle-invasive form of BC develops in about 25% of pa...

    Authors: Sameh M. Farouk, Asmaa F. Khafaga and Ahmed M. Abdellatif
    Citation: Cancer Cell International 2023 23:251
  15. Cancer Stem Cells (CSCs) are the main “seeds” for the initiation, growth, metastasis, and recurrence of tumors. According to many studies, several viral infections, including the human papillomaviruses, hepati...

    Authors: Amirhosein Faghihkhorasani, Alaleh Dalvand, Ehsan Derafsh, Farnaz Tavakoli, Nada Khairi Younis, Saman Yasamineh, Omid Gholizadeh and Pooria Shokri
    Citation: Cancer Cell International 2023 23:250
  16. Alternative pre-mRNA splicing is a critical mechanism that generates multiple mRNA from a single gene, thereby increasing the diversity of the proteome. Recent research has highlighted the significance of spec...

    Authors: Sunkyung Choi, Namjoon Cho, Eun-Mi Kim and Kee K. Kim
    Citation: Cancer Cell International 2023 23:249
  17. An immunosuppressive tumor microenvironment in ovarian cancer facilitates tumor progression and resistance to immunotherapy. The function of MYB Proto-Oncogene Like 2 (MYBL2) in the tumor microenvironment rema...

    Authors: Baoyue Pan, Ting Wan, Yun Zhou, Shuting Huang, Linjing Yuan, Yinan Jiang, Xiaojing Zheng, Pingping Liu, Huiling Xiang, Mingxiu Ju, Rongzhen Luo, Weihua Jia, ChunYan Lan, Jundong Li and Min Zheng
    Citation: Cancer Cell International 2023 23:248
  18. Prostate cancer (PCa) is a non-cutaneous malignancy in males with wide variation in incidence rates across the globe. It is the second most reported cause of cancer death. Its etiology may have been linked to ...

    Authors: Khurram Rehman, Zoya Iqbal, Deng Zhiqin, Hina Ayub, Naseem Saba, Muzammil Ahamd Khan, Liang Yujie and Li Duan
    Citation: Cancer Cell International 2023 23:247
  19. RAD51B plays a significant role in homologous recombination-mediated repair of DNA double-strand breaks. Many enhancer variants are involved in cancer development and progression. However, the significance of ...

    Authors: Liming Huang, Wenshen Xu, Danfang Yan, Xi Shi, Shu Zhang, Meiqin Chen and Lian Dai
    Citation: Cancer Cell International 2023 23:246
  20. GAS41, a member of the human YEATS domain family, plays a pivotal role in human cancer development. It serves as a highly promising epigenetic reader, facilitating precise regulation of cell growth and develop...

    Authors: Kangkang Ji, Li Li, Hui Liu, Yucheng Shen, Jian Jiang, Minglei Zhang, Hongwei Teng, Xun Yan, Yanhua Zhang, Yong Cai and Hai Zhou
    Citation: Cancer Cell International 2023 23:245
  21. Primary hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality. KH domain-containing, RNA-binding signal transduction-associated protein 3 (KHDRBS3) is an RNA-binding protein that is ...

    Authors: Mingda Zhao, Yibing Zhang, Longfei Li, Xiaobin Liu, Wenping Zhou, Chunhui Wang and Yufu Tang
    Citation: Cancer Cell International 2023 23:244
  22. Drug resistance is a major obstacle causing chemotherapy failure, and enabling cancer progression. Exosome excreted by cancer cells is participated in cancer progression and chemoresistance, and can be used as...

    Authors: Xiao-Xue Qiao, Hui-Bo Shi and Li Xiao
    Citation: Cancer Cell International 2023 23:243
  23. Epigenetic modifications have long been recognized as an essential level in transcriptional regulation linking behavior and environmental conditions or stimuli with biological processes and disease development...

    Authors: Chengyin Liu, Han Tang, Nana Hu and Tianbao Li
    Citation: Cancer Cell International 2023 23:242
  24. MicroRNAs (miRNAs) are a group of small non-coding RNAs that affect gene expression. The role of miRNAs in different types of cancers has been published and it was shown that several miRNAs are inappropriately...

    Authors: Chunguang Wang, Meiling Bai, Zhiguang Sun, Nan Yao, Aiting Zhang, Shengyu Guo and Zatollah Asemi
    Citation: Cancer Cell International 2023 23:241
  25. Triple-negative breast cancer (TNBC) cells’ secretome can induce a pro-inflammatory phenotype in human adipose-derived mesenchymal stem cells (hADMSC). This can be prevented by the green tea polyphenol epigall...

    Authors: Narjara Gonzalez Suarez, Yuniel Fernandez-Marrero, Mathieu P. A. Hébert, Marie-Eve Roy, Luc H. Boudreau and Borhane Annabi
    Citation: Cancer Cell International 2023 23:240
  26. Hepatocellular carcinoma (HCC) is the most predominant primary liver cancer, causing many illnesses and deaths worldwide. The insidious clinical presentation, difficulty in early diagnosis, and the highly mali...

    Authors: Kaige Deng, Jiali Xing, Gang Xu, Bao Jin, Xueshuai Wan, Yongchang Zheng, Shunda Du and Xinting Sang
    Citation: Cancer Cell International 2023 23:239
  27. Glioma is the most aggressive and malignant type of primary brain tumor, comprises the majority of central nervous system deaths, and is categorized into different subgroups according to its histological chara...

    Authors: Peyman Tabnak, Aysa Hasanzade Bashkandi, Mohammad Ebrahimnezhad and Mahdieh Soleimani
    Citation: Cancer Cell International 2023 23:238
  28. Lysine Demethylase 2A (KDM2A) plays a crucial role in cancer cell growth, differentiation, metastasis, and the maintenance of cancer stemness. Our previous study found that cancer-secreted IL-6 can upregulate ...

    Authors: Jia-Shing Chen, Yu-Ning Teng, Cheng-Yi Chen and Jing-Yi Chen
    Citation: Cancer Cell International 2023 23:237
  29. Breast cancer (BC) is the most common malignancy with very high incidence and relatively high mortality in women. The PIK3CA gene plays a pivotal role in the pathogenicity of breast cancer. Despite this, the m...

    Authors: Rahul Kumar, Rakesh Kumar, Harsh Goel, Sonu Kumar, Somorjit Singh Ningombam, Imran Haider, Usha Agrawal, Svs Deo, Ajay Gogia, Atul Batra, Ashok Sharma, Sandeep Mathur, Amar Ranjan, Anita Chopra, Showket Hussain and Pranay Tanwar
    Citation: Cancer Cell International 2023 23:236
  30. Drug resistance is a main factor affecting the chemotherapy efficacy of gastric cancer (GC), in which meiosis plays an important role. Therefore, it is urgent to explore the effect of meiosis related genes on ...

    Authors: Xiaosi Hu, Shuai Zhou, Haohao Li, Zehui Wu, Ye Wang, Lei Meng, Zhangming Chen, Zhijian Wei, Qing Pang and Aman Xu
    Citation: Cancer Cell International 2023 23:234
  31. Surgery and chemo-radiotherapy are used as the common first-line treatment options in many cancers. However, tumor relapse is observed in many cancer patients following such first-line treatments. Therefore, t...

    Authors: Negin Taghehchian, Amirhosein Maharati, Iman Akhlaghipour, Amir Sadra Zangouei and Meysam Moghbeli
    Citation: Cancer Cell International 2023 23:233
  32. Ovarian cancer (OV) is the most lethal gynecological malignancies worldwide. The coagulation cascade could induce tumor cell infiltration and contribute to OV progression. However, coagulation-related gene (CR...

    Authors: Jiani Yang, Chao Wang, Yue Zhang, Shanshan Cheng, Meixuan Wu, Sijia Gu, Shilin Xu, Yongsong Wu, Jindan Sheng, Dominic Chih-Cheng Voon and Yu Wang
    Citation: Cancer Cell International 2023 23:232
  33. RAD51 overexpression has been reported to serve as a marker of poor prognosis in several cancer types. This study aimed to survey the role of RAD51 in oral squamous cell carcinoma and whether RAD51 could be a ...

    Authors: Yu-Fen Tsai, Leong-Perng Chan, Yuk-Kwan Chen, Chang-Wei Su, Ching-Wei Hsu, Yen-Yun Wang and Shyng-Shiou F. Yuan
    Citation: Cancer Cell International 2023 23:231
  34. Mutations in the KEAP1-NFE2L2 signaling pathway were linked to increased tumorigenesis and aggressiveness. Interestingly, not all hotspot mutations on NFE2L2 were damaging; some even were activating. However, ...

    Authors: Kewei Wang, Zixi Li, Ying Xuan, Yong Zhao, Chao Deng, Meidan Wang, Chenjun Xie, Fenglai Yuan, Qingfeng Pang, Wenjun Mao, Dongyan Cai, Zhangfeng Zhong and Jie Mei
    Citation: Cancer Cell International 2023 23:229
  35. Melanoma is the deadliest type of skin cancer and despite improvements in treatment outcomes, melanoma claimed 57,043 lives in 2020. In most malignancies, p53 mutation rates are above 50% and provide prognosti...

    Authors: Kira Groen, Luiza Steffens Reinhardt, Jean-Christophe Bourdon and Kelly A. Avery-Kiejda
    Citation: Cancer Cell International 2023 23:228
  36. Glioma is the most common and lethal type of brain tumor, and it is characterized by unfavorable prognosis and high recurrence rates. The reprogramming of energy metabolism and an immunosuppressive tumor micro...

    Authors: Shupeng Li, Ziwei Li, Xinyu Wang, Junzhe Zhong, Daohan Yu, Hao Chen, Wenbin Ma, Lingling Liu, Minghuang Ye, Ruofei Shen, Chuanlu Jiang, Xiangqi Meng and Jinquan Cai
    Citation: Cancer Cell International 2023 23:227
  37. N6-methyladenosine(m6A), is the most abundant post-transcriptional modification of mRNA in biology. When the first nucleotide after the m7G cap is adenosine, it is methylated at the N6 position to form N6,2-O-...

    Authors: Yuting Wu, Xi Pu, Sihui Wu, Yiran Zhang, Shengqiao Fu, Haowen Tang, Xu Wang and Min Xu
    Citation: Cancer Cell International 2023 23:226
  38. Post-translational modifications (PTMs) of proteins contribute to the occurrence and development of tumors. Previous studies have suggested that canonical PTMs such as ubiquitination, glycosylation, and phosph...

    Authors: Yihong Liu, Jingwei Liu, Na Peng, Shuangshuang Hai, Shen Zhang, Haibo Zhao and Weixin Liu
    Citation: Cancer Cell International 2023 23:225
  39. Hyper progressive disease (HPD) describes the phenomenon that patients can’t benefit from immunotherapy but cause rapid tumor progression. HPD is a particular phenomenon in immunotherapy but lacks prediction m...

    Authors: Yaping Long, Wenyu Yang, Yibing Bai, Haitao Tao, Fan Zhang, Lijie Wang, Bo Yang, Di Huang, Xiao Han and Yi Hu
    Citation: Cancer Cell International 2023 23:224
  40. High-grade serous ovarian cancer (HGSOC) is a challenging malignancy characterized by complex interactions between tumor cells and the surrounding microenvironment. Understanding the immune landscape of HGSOC,...

    Authors: Qihui Wu, Xiaoyun He, Jiaxin Liu, Chunlin Ou, Yimin Li and Xiaodan Fu
    Citation: Cancer Cell International 2023 23:223
  41. According to the latest epidemiological investigation, lung adenocarcinoma (LUAD) is one of the most fatal cancer among both men and women. Despite continuous advancements in treatment approaches in recent yea...

    Authors: Pengdou Zheng, Zhenyu Mao, Miao Luo, Ling Zhou, Lingling Wang, Huiguo Liu, Wei Liu and Shuang Wei
    Citation: Cancer Cell International 2023 23:222
  42. Bladder cancer (BCa) is one of the most common malignancies worldwide. However, the lack of accurate and effective targeted drugs has become a major problem in current clinical treatment of BCa. Studies have d...

    Authors: Fan Zou, Wu Chen, Tianbao Song, Ji Xing, Yunlong Zhang, Kang Chen, Weimin Hu, Linzhi Li, Jinzhuo Ning, Chenglong Li, Weimin Yu and Fan Cheng
    Citation: Cancer Cell International 2023 23:221
  43. Myosin heavy chain 9 (MYH9) plays an important role in a number of diseases. Nevertheless, the function of MYH9 in glioma is unclear. The present research aimed to investigate the role of MYH9 in glioma and de...

    Authors: Zigui Chen, Xin Yan, Changfeng Miao, Longyang Liu, Su Liu, Ying Xia, Weiyi Fang, Dandan Zheng and Qisheng Luo
    Citation: Cancer Cell International 2023 23:220
  44. Recently, natural killer (NK) cells emerged as a treatment option for various solid tumors. However, the immunosuppressive tumor immune microenvironment (TIME) can reduce the cytotoxic ability of NK cells in p...

    Authors: Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee and Hyo-Jeong Kuh
    Citation: Cancer Cell International 2023 23:219
  45. Disulfidptosis is independent of apoptosis, ferroptosis, and cuproptosis and is associated with cancer progression, treatment response, and prognosis. However, the predictive potential of disulfidptosis-associ...

    Authors: Weijie Xue, Kang Qiu, Bingzi Dong, Dong Guo, Junhua Fu, Chengzhan Zhu and Zhaojian Niu
    Citation: Cancer Cell International 2023 23:218

Annual Journal Metrics

  • 2022 Citation Impact
    5.8 - 2-year Impact Factor
    5.6 - 5-year Impact Factor
    0.994 - SNIP (Source Normalized Impact per Paper)
    1.145 - SJR (SCImago Journal Rank)

    2022 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    116 days submission to accept (Median)

    2022 Usage 
    2,208,493 downloads
    1,520 Altmetric mentions 

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here